Analyst consensus rating
Purple Biotech Analyst Rating: none
Direct answer
Purple Biotech's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.00.
Forecast evidence checked October 17, 2026.
Get free Purple Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.14
- Average price target
- $17.00
- High price target
- $17.00
- Low price target
- $17.00
- Low target gap
- +1,391.2%
- Target upside
- +1,391.2%
- High target gap
- +1,391.2%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Purple Biotech?
Purple Biotech has a verified none consensus. The same dataset has an average price target of $17.00.
How far are Purple Biotech's low and high targets from the recorded price?
The low target implies +1,391.2%, while the high target implies +1,391.2%.
How many analysts are included in Purple Biotech's consensus?
The verified consensus includes 1 analysts.
How is Purple Biotech's target upside or downside calculated?
The average target of $17.00 is divided by the recorded price of $1.14, then one is subtracted to produce +1,391.2%. This does not guarantee a future return.
When was Purple Biotech's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.